Home > Insider Trading > Filing (0000899243-19-022201)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596946	Quotient Ltd	QTNT	In Vitro & In Vivo Diagnostic Substances (2835)	264719797

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1604830	Roland Boyd	C/O Quotient Limited 28 Esplanade St Helier Y9 JE2 3QA	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2019-08-19	32,000	$0.00	62,508	No	4	M	Direct
Ordinary Shares	Acquisiton	2019-08-19	8,000	$3.29	70,508	No	4	M	Direct
Ordinary Shares	Acquisiton	2019-08-19	21,100	$8.00	91,608	No	4	M	Direct
Ordinary Shares	Disposition	2019-08-19	21,100	$10.95	70,508	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Employee Stock Option (right to buy)	Disposition	2019-08-19	21,100	$0.00	21,100	$8.00
Ordinary Shares	Options to purchase ordinary shares	Disposition	2019-08-19	32,000	$0.00	32,000	$0.00
Ordinary Shares	Options to purchase ordinary shares	Disposition	2019-08-19	8,000	$0.00	8,000	$3.29

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,900	2024-04-29	No	4	M	Direct
0	2023-02-14	No	4	M	Direct
0	2023-06-27	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Ordinary Shares	Employee Stock Option (right to buy)	$11.92	2026-05-31	15,000	15,000	Direct
Ordinary Shares	Employee Stock Option (right to buy)	$15.17	2025-05-19	15,000	15,000	Direct
Ordinary Shares	Employee Stock Option (right to buy)	$7.58	2027-05-23	13,000	13,000	Direct
Ordinary Shares	Multi-year Performance Based Restricted Stock Unit	$0.00	2019-12-31	6,000	6,000	Direct
Ordinary Shares	Restricted Stock Units	$0.00		6,667	6,667	Direct
Ordinary Shares	Restricted Stock Units	$0.00		20,000	20,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2026-05-31	15,000	15,000	Direct
2025-05-19	15,000	15,000	Direct
2027-05-23	13,000	13,000	Direct
2019-12-31	6,000	6,000	Direct
	6,667	6,667	Direct
	20,000	20,000	Direct

Footnotes

10,000 options have vested and remain exercisable and 5,000 options will vest on June 1, 2019.
All 15,000 options have vested and remain exercisable.
All 25,000 options have vested and remain exercisable.
The exercise price will be paid in pounds sterling, at GBP 0.91 per share.
All 32,000 options have vested and remain exercisable.
All 8,000 options have vested and remain exercisable.
8,666 options have vested and remain exercisable. 4,334 options will vest on May 24, 2020.
Each Multi-year Performance Based Restricted Stock Unit ("MRSU") represents a contingent right to receive one share of Quotient's ordinary shares. The MRSUs vest upon Quotient's ordinary shares achieving a volume weighted average market price of $22.00 per share for 20 consecutive trading days during the period April 1, 2019 to December 31, 2019.
Restricted Stock Units convert into ordinary shares on a one-for-one basis.
On May 24, 2018, the Reporting Person was granted 10,000 Restricted Stock Units, of which 3,333 have vested and have been exercised. The remaining 6,667 Restricted Stock Units will vest in two equal installments on May 24, 2020 and May 24, 2021.
On May 24, 2019, the Reporting Person was granted 20,000 Restricted Stock Units, vesting in three equal annual installments beginning May 24, 2020.